Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN)

Today, Nervgen Pharma Corp shares closed at $2.37 after opening the day at $2.42. It traded at a low of $2.33 to a high of $2.44.

Share prices dipped -2.47% from the previous day's close of $2.43.

Today across North America, the TSX Composite closed -1.20% at 21698.11, the S&P 500 closed 0.85% at 5421.03, the Dow Jones Industrial Average closed -0.09% at 38712.21 and the Nasdaq Composite closed 1.53% at 17608.44.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 124,575 shares was traded during the last trading day, with total trades of 224, with an average volume of 224,147 over the last 5 days.

Trading across the entire TSX-V saw 1,600 price advancers against 3,644 declines and 110 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 38.60 percent in the last year, while this year, they have dipped -12.22%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $169.92 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..